Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
filingDate |
2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2011517673-A |
titleOfInvention |
Aromatic heterocycle fused indolobenzdiazepine HCVNS5B inhibitor |
abstract |
The present invention provides compounds of formula I and salts thereof, as well as compositions and methods using the compounds. The compound has activity against hepatitis C virus (HCV) and is useful for the treatment of persons infected with HCV. |
priorityDate |
2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |